Ovarian Cancer
Our major research goal is to identify new ways to diagnose women
with early stage curable ovarian cancer. To this end, we use a
combination of genetic and epigenetic approaches to understand the
molecular changes involved in the development of ovarian cancer.
Together with the Epigenetics Group, our current primary focus is the
identification of a panel of methylated genes that may have potential
as diagnostic markers for early stage ovarian cancer. These markers
will likely include genes that control the development of ovarian
cancer, and therefore may also include potential novel therapeutic
targets for treatment of advanced disease.
Staff
| Research Officer Celine Montavon |
Research Officer Kristina Warton |
Maria Gonzales |
Kate Patterson |
| PhD Student Gabriella Matta |
PhD Student Brian Gloss |
| Data Entry
Clerk Jacqueline Gerharty |
News
Garvan and St Vincent’s to Build $100 million Australian Cancer Centre
MEDIA RELEASE:
22 Oct 2008
The Garvan Institute of Medical Research and St Vincents & Mater Health Sydney will today announce plans to jointly establish a new $100 million Cancer Centre within the St Vincent’s Research Precinct. The Garvan St Vincent’s Campus Cancer Centre (GSVCCC) will integrate internationally acclaimed cancer research with best practice cancer services, enabling research findings to move quickly into patient care.
